| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.
|
Clin Chem
|
1997
|
4.77
|
|
2
|
Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.
|
JAMA
|
2004
|
4.54
|
|
3
|
Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas.
|
Infect Agents Dis
|
1993
|
3.07
|
|
4
|
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.
|
Arterioscler Thromb Vasc Biol
|
1997
|
2.76
|
|
5
|
Association between physical activity and markers of inflammation in a healthy elderly population.
|
Am J Epidemiol
|
2001
|
2.68
|
|
6
|
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.
|
Arterioscler Thromb Vasc Biol
|
1999
|
2.15
|
|
7
|
Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies.
|
Circulation
|
2002
|
1.85
|
|
8
|
Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology.
|
Am J Epidemiol
|
1999
|
1.73
|
|
9
|
In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease.
|
Arterioscler Thromb Vasc Biol
|
2002
|
1.70
|
|
10
|
C-reactive protein and the future risk of thromboembolic stroke in healthy men.
|
Circulation
|
2003
|
1.32
|
|
11
|
Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
|
Thromb Haemost
|
2001
|
1.27
|
|
12
|
Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective.
|
Chest
|
2003
|
1.16
|
|
13
|
C-reactive protein and myocardial infarction.
|
J Clin Epidemiol
|
2002
|
1.14
|
|
14
|
Hormone replacement therapy, inflammation, and hemostasis in elderly women.
|
Arterioscler Thromb Vasc Biol
|
1999
|
1.04
|
|
15
|
Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes.
|
Arterioscler Thromb Vasc Biol
|
1998
|
1.02
|
|
16
|
Inflammation markers and coronary heart disease.
|
Curr Opin Lipidol
|
1999
|
1.01
|
|
17
|
Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction.
|
Am J Clin Nutr
|
1996
|
0.88
|
|
18
|
No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study.
|
Thromb Haemost
|
2002
|
0.83
|
|
19
|
Variability in plasma prothrombin concentration: implications for use in epidemiology.
|
Blood Coagul Fibrinolysis
|
1998
|
0.75
|